BIOMAT Database Logo BIOMAT Database Logo

Minimal change nephropathy and focal segmental glomerulosclerosis. 1997

N P Mallick, and P E Brenchley, and N J Webb
Department of Renal Medicine, Manchester University, England, United Kingdom.

UI MeSH Term Description Entries
D009402 Nephrosis, Lipoid A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA. Glomerulonephritis, Minimal Change,Glomerulopathy, Minimal Change,Nephropathy, Minimal Change,Nephrotic Syndrome, Minimal Change,Idiopathic Minimal Change Nephrotic Syndrome,Minimal Change Disease,Minimal Change Glomerulopathy,Minimal Change Nephrotic Syndrome,Change Diseases, Minimal,Disease, Minimal Change,Diseases, Minimal Change,Glomerulonephritides, Minimal Change,Glomerulopathies, Minimal Change,Lipoid Nephroses,Lipoid Nephrosis,Minimal Change Diseases,Minimal Change Glomerulonephritides,Minimal Change Glomerulonephritis,Minimal Change Nephropathies,Minimal Change Nephropathy,Nephropathies, Minimal Change,Nephroses, Lipoid
D005923 Glomerulosclerosis, Focal Segmental A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE. Glomerulonephritis, Focal Sclerosing,Hyalinosis, Segmental Glomerular,Focal Segmental Glomerulosclerosis,Glomerulosclerosis, Focal,Hyalinosis, Segmental,Segmental Glomerular Hyalinosis,Focal Glomerulosclerosis,Focal Sclerosing Glomerulonephritides,Focal Sclerosing Glomerulonephritis,Glomerular Hyalinosis, Segmental,Glomerulonephritides, Focal Sclerosing,Sclerosing Glomerulonephritides, Focal,Sclerosing Glomerulonephritis, Focal,Segmental Glomerulosclerosis, Focal,Segmental Hyalinosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N P Mallick, and P E Brenchley, and N J Webb
Minimal change nephropathy and focal segmental glomerulosclerosis.
November 2007, Seminars in immunopathology,
N P Mallick, and P E Brenchley, and N J Webb
The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
January 1997, Journal of the Royal College of Physicians of London,
N P Mallick, and P E Brenchley, and N J Webb
Minimal change disease and focal segmental glomerulosclerosis.
January 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
N P Mallick, and P E Brenchley, and N J Webb
[Minimal change disease and focal segmental glomerulosclerosis].
May 2019, Der Internist,
N P Mallick, and P E Brenchley, and N J Webb
Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
January 1997, Journal of the Royal College of Physicians of London,
N P Mallick, and P E Brenchley, and N J Webb
Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis.
February 2001, Kidney international,
N P Mallick, and P E Brenchley, and N J Webb
Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
October 2015, Clinical nephrology,
N P Mallick, and P E Brenchley, and N J Webb
Rituximab in minimal change disease and focal segmental glomerulosclerosis.
May 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
N P Mallick, and P E Brenchley, and N J Webb
IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
August 2016, Journal of nephrology,
N P Mallick, and P E Brenchley, and N J Webb
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
January 2014, Nephron. Clinical practice,
Copied contents to your clipboard!